DOGWOOD THERAPEUTICS INC (DWTX) Fundamental Analysis & Valuation

NASDAQ:DWTX • US92829J2033

Current stock price

1.99 USD
+0.01 (+0.51%)
At close:
1.95 USD
-0.04 (-2.01%)
After Hours:

This DWTX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DWTX Profitability Analysis

1.1 Basic Checks

  • DWTX had negative earnings in the past year.
  • DWTX had a negative operating cash flow in the past year.
  • DWTX had negative earnings in each of the past 5 years.
  • DWTX had a negative operating cash flow in each of the past 5 years.
DWTX Yearly Net Income VS EBIT VS OCF VS FCFDWTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M

1.2 Ratios

  • DWTX has a Return On Assets of -39.39%. This is comparable to the rest of the industry: DWTX outperforms 55.90% of its industry peers.
  • DWTX's Return On Equity of -47.42% is fine compared to the rest of the industry. DWTX outperforms 63.83% of its industry peers.
Industry RankSector Rank
ROA -39.39%
ROE -47.42%
ROIC N/A
ROA(3y)-60.06%
ROA(5y)-85.53%
ROE(3y)-68.85%
ROE(5y)-96.75%
ROIC(3y)N/A
ROIC(5y)N/A
DWTX Yearly ROA, ROE, ROICDWTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for DWTX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DWTX Yearly Profit, Operating, Gross MarginsDWTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. DWTX Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, DWTX has more shares outstanding
  • The number of shares outstanding for DWTX has been increased compared to 5 years ago.
  • There is no outstanding debt for DWTX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DWTX Yearly Shares OutstandingDWTX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
DWTX Yearly Total Debt VS Total AssetsDWTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

  • DWTX has an Altman-Z score of -0.02. This is a bad value and indicates that DWTX is not financially healthy and even has some risk of bankruptcy.
  • DWTX has a Altman-Z score of -0.02. This is comparable to the rest of the industry: DWTX outperforms 57.06% of its industry peers.
  • DWTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.02
ROIC/WACCN/A
WACCN/A
DWTX Yearly LT Debt VS Equity VS FCFDWTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M

2.3 Liquidity

  • DWTX has a Current Ratio of 2.76. This indicates that DWTX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.76, DWTX is doing worse than 66.73% of the companies in the same industry.
  • DWTX has a Quick Ratio of 2.76. This indicates that DWTX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.76, DWTX is doing worse than 64.22% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.76
Quick Ratio 2.76
DWTX Yearly Current Assets VS Current LiabilitesDWTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. DWTX Growth Analysis

3.1 Past

  • DWTX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -32.33%.
EPS 1Y (TTM)-32.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.81%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 24.54% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y94.14%
EPS Next 2Y39.04%
EPS Next 3Y24.54%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DWTX Yearly Revenue VS EstimatesDWTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 20M 40M 60M 80M 100M
DWTX Yearly EPS VS EstimatesDWTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -10 -20 -30 -40 -50

More info and screens

Find the best growth stocksShow best growing peers

1

4. DWTX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DWTX. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DWTX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DWTX Price Earnings VS Forward Price EarningsDWTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DWTX Per share dataDWTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10

4.3 Compensation for Growth

  • DWTX's earnings are expected to grow with 24.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.04%
EPS Next 3Y24.54%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DWTX Dividend Analysis

5.1 Amount

  • DWTX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DWTX Fundamentals: All Metrics, Ratios and Statistics

DOGWOOD THERAPEUTICS INC

NASDAQ:DWTX (4/10/2026, 8:18:10 PM)

After market: 1.95 -0.04 (-2.01%)

1.99

+0.01 (+0.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-18
Earnings (Next)05-06
Inst Owners11.05%
Inst Owner Change0%
Ins Owners0.01%
Ins Owner Change99.03%
Market Cap66.47M
Revenue(TTM)N/A
Net Income(TTM)-35.51M
Analysts82.5
Price Target14.28 (617.59%)
Short Float %0.61%
Short Ratio0.96
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-231.09%
Min EPS beat(2)-556.26%
Max EPS beat(2)94.08%
EPS beat(4)1
Avg EPS beat(4)-134.46%
Min EPS beat(4)-556.26%
Max EPS beat(4)94.08%
EPS beat(8)2
Avg EPS beat(8)-120.54%
EPS beat(12)5
Avg EPS beat(12)-70.24%
EPS beat(16)9
Avg EPS beat(16)-46.36%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-26.32%
PT rev (3m)-23.64%
EPS NQ rev (1m)47.62%
EPS NQ rev (3m)47.62%
EPS NY rev (1m)80.59%
EPS NY rev (3m)80.59%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.89
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-14.45
EYN/A
EPS(NY)-0.85
Fwd EYN/A
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.47
OCFYN/A
SpS0
BVpS2.24
TBVpS-0.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -39.39%
ROE -47.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-60.06%
ROA(5y)-85.53%
ROE(3y)-68.85%
ROE(5y)-96.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.76
Quick Ratio 2.76
Altman-Z -0.02
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.81%
EPS Next Y94.14%
EPS Next 2Y39.04%
EPS Next 3Y24.54%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-117.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-77.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-77.67%
OCF growth 3YN/A
OCF growth 5YN/A

DOGWOOD THERAPEUTICS INC / DWTX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DOGWOOD THERAPEUTICS INC (DWTX) stock?

ChartMill assigns a fundamental rating of 2 / 10 to DWTX.


What is the valuation status for DWTX stock?

ChartMill assigns a valuation rating of 1 / 10 to DOGWOOD THERAPEUTICS INC (DWTX). This can be considered as Overvalued.


How profitable is DOGWOOD THERAPEUTICS INC (DWTX) stock?

DOGWOOD THERAPEUTICS INC (DWTX) has a profitability rating of 1 / 10.


Can you provide the financial health for DWTX stock?

The financial health rating of DOGWOOD THERAPEUTICS INC (DWTX) is 6 / 10.


What is the earnings growth outlook for DOGWOOD THERAPEUTICS INC?

The Earnings per Share (EPS) of DOGWOOD THERAPEUTICS INC (DWTX) is expected to grow by 94.14% in the next year.